Bladder Cancer Invasion is Mediated by mTORC2-Driven Regulation of Nitric Oxide and Invadopodia Formation.

[1]  E. Petricoin,et al.  Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. , 2019, The American journal of pathology.

[2]  Dana M. Brantley-Sieders,et al.  Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. , 2018, Cancer research.

[3]  R. Nawroth,et al.  Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer. , 2018, Methods in molecular biology.

[4]  T. Weichhart,et al.  mTORC1 and mTORC2 as regulators of cell metabolism in immunity , 2017, FEBS letters.

[5]  Y. Lotan,et al.  Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer , 2017, Cancer medicine.

[6]  Tariq Bashir,et al.  Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma , 2017, PloS one.

[7]  Jing-jing Hu,et al.  mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. , 2017, Cellular signalling.

[8]  D. Hansel,et al.  Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. , 2017, The American journal of pathology.

[9]  B. Delahunt,et al.  A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma. , 2016, Pathology.

[10]  G. Boss,et al.  The Vitamin B12 Analog Cobinamide Is an Effective Antidote for Oral Cyanide Poisoning , 2016, Journal of Medical Toxicology.

[11]  Zhihui Yao,et al.  Nitric Oxide Enhances Keratinocyte Cell Migration by Regulating Rho GTPase via cGMP-PKG Signalling , 2015, PloS one.

[12]  E. D. Bal de Kier Joffé,et al.  Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor , 2015, Journal of Cancer Research and Clinical Oncology.

[13]  G. Boss,et al.  Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model. , 2014, Annals of emergency medicine.

[14]  M. Fujita,et al.  Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K–AKT and RhoA pathways after carbon ion irradiation , 2014, FEBS letters.

[15]  Xin Li,et al.  mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity , 2014, EMBO reports.

[16]  Jing Dong,et al.  Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor. , 2014, Molecular medicine reports.

[17]  Yong-jie Lu,et al.  Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. , 2014, Cancer Research.

[18]  D. Hansel,et al.  Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion , 2013, PloS one.

[19]  K. Rajalingam,et al.  Small Rho GTPases in the control of cell shape and mobility , 2013, Cellular and Molecular Life Sciences.

[20]  G. Apodaca,et al.  Bladder filling and voiding affect umbrella cell tight junction organization and function. , 2013, American journal of physiology. Renal physiology.

[21]  Xiayang Xie,et al.  Evaluating human cancer cell metastasis in zebrafish , 2013, BMC Cancer.

[22]  T. Brüning,et al.  Cross-Contamination of a UROtsa Stock with T24 Cells – Molecular Comparison of Different Cell Lines and Stocks , 2013, PloS one.

[23]  Luigi Preziosi,et al.  Time‐dependent traction force microscopy for cancer cells as a measure of invasiveness , 2013, Cytoskeleton.

[24]  O. Sanli,et al.  Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases. , 2012, The Journal of urology.

[25]  P. D. de Verdier,et al.  Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer. , 2012, Nitric oxide : biology and chemistry.

[26]  R. Klemke.  Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culprits. , 2012, Current opinion in cell biology.

[27]  R. Klemke,et al.  Proteomics method for identification of pseudopodium phosphotyrosine proteins. , 2012, Methods in molecular biology.

[28]  Tyler E. Miller,et al.  Myosin II isoform switching mediates invasiveness after TGF-β–induced epithelial–mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[29]  V. Zinzalla,et al.  Activation of mTORC2 by Association with the Ribosome , 2011, Cell.

[30]  G. Boss,et al.  Cobinamide is superior to other treatments in a mouse model of cyanide poisoning , 2010, Clinical toxicology.

[31]  Jing Yang,et al.  Visualizing extravasation dynamics of metastatic tumor cells , 2010, Journal of Cell Science.

[32]  Shuhei Yoshida,et al.  Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. , 2009, Cancer research.

[33]  M. Ohh,et al.  Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2* , 2008, Journal of Biological Chemistry.

[34]  Shile Huang,et al.  Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins , 2008, Oncogene.

[35]  B. Jasani,et al.  Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma , 2008, British Journal of Cancer.

[36]  C. Sternberg.  Muscle invasive and metastatic bladder cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  S. Kılıç,et al.  Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer? , 2006, International journal of urology : official journal of the Japanese Urological Association.

[38]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[39]  L. Giménez,et al.  Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients. , 2005, Nitric oxide : biology and chemistry.

[40]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[41]  M. Lisanti,et al.  The caveolin proteins , 2004, Genome Biology.

[42]  F. Coulet,et al.  Identification of Hypoxia-response Element in the Human Endothelial Nitric-oxide Synthase Gene Promoter* , 2003, Journal of Biological Chemistry.

[43]  Shao-xing Zhu,et al.  Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis , 2003, Urological Research.

[44]  J. Pouysségur,et al.  Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms* , 2002, The Journal of Biological Chemistry.

[45]  A. Eiján,et al.  Nitric oxide in patients with transitional bladder cancer , 2002, Journal of surgical oncology.

[46]  U. Engelmann,et al.  Nitric oxide pathways in human bladder carcinoma , 2002, Cancer.

[47]  A. Hochberg,et al.  Nitric oxide synthase immunoreactivity in human bladder carcinoma , 2001, Molecular pathology : MP.

[48]  U. Engelmann,et al.  Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. , 2001, The Journal of urology.

[49]  Xiaoping Liu,et al.  The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Roessner,et al.  Inducible nitric oxide synthase expression in human urinary bladder cancer , 2000, Virchows Archiv.

[51]  U. Engelmann,et al.  Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. , 1999, Urology.

[52]  Xiaoping Liu,et al.  Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Starzinski-Powitz,et al.  Invasiveness of endometriotic cells in vitro , 1995, The Lancet.

[54]  A. Sica,et al.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter , 1995, The Journal of experimental medicine.